Sbi Securities Co., Ltd. Coherus Bio Sciences, Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.48 Trillion
- Q2 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 724 shares of CHRS stock, worth $666. This represents 0.0% of its overall portfolio holdings.
Number of Shares
724
Previous 3,724
80.56%
Holding current value
$666
Previous $3.01 Million
82.4%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CHRS
# of Institutions
121Shares Held
63.2MCall Options Held
127KPut Options Held
65.3K-
Black Rock Inc. New York, NY11.8MShares$10.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$9.72 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY5.26MShares$4.84 Million0.12% of portfolio
-
Tang Capital Management LLC San Diego, CA5.1MShares$4.69 Million0.27% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY3.04MShares$2.79 Million0.11% of portfolio
About Coherus BioSciences, Inc.
- Ticker CHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,724,600
- Market Cap $71.5M
- Description
- Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...